TrialCancer chemotherapy and pharmacology2023

Safety and pharmacokinetics of GB1211, an oral galectin-3 inhibitor: a single- and multiple-dose first-in-human study in healthy participants.

Vassilios Aslanis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.